Literature DB >> 30098261

[Association of vascular endothelial growth factor gene polymorphisms with Crohn's disease among Chinese patients].

Jihua Pei1, Liqin Yu, Xuanping Xia, Shenglong Xia, Xiuqing Lin, Jie Jin, Yi Jiang.   

Abstract

OBJECTIVE: To assess the association of vascular endothelial growth factor (VEGF) gene polymorphisms with susceptibility to Crohn's disease (CD) in a Chinese population.
METHODS: For 275 CD patients and 495 controls, the genotypes of VEGF gene rs699947 and rs3025039 loci were determined with a SNaPshot method.
RESULTS: The allelic and genotypic frequencies of the rs699947 and rs3025039 loci did not differ between the two groups (all P>0.05). By stratification analysis, allele A and genotype CA+AA of rs699947 were more frequent in patients with colonic CD compared with the controls (P=0.006, 95%CI:1.143-2.234; P=0.005, 95%CI:1.203-2.900, respectively). Compared with the controls, the allele A and genotype CA+AA of rs699947 were less frequent in patients with ileal lesions including ileal CD and ileocolonic CD (P=0.033, 95%CI:0.524-0.974;P=0.043, 95%CI:0.481-0.989, respectively). The frequency of TT homozygote of rs3025039 was lower in patients with non-stricturing and non-penetrating CD compared with the controls (P=0.036, 95%CI:0.016-0.870).
CONCLUSION: Polymorphisms of the VEGF gene rs699947 locus may contribute to an increased risk for colonic CD, but may play a protective role in patients with ileal lesion. Individuals carrying the TT genotype for VEGF rs3025039 locus may be less susceptible to non-stricturing and non-penetrating CD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30098261     DOI: 10.3760/cma.j.issn.1003-9406.2018.04.027

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  1 in total

1.  A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn's disease.

Authors:  Jing Zhang; Qifeng Huang; Rui Zhao; Zhiyuan Ma
Journal:  BMC Complement Med Ther       Date:  2020-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.